États-Unis · Plateformes & données · Finviz

DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination

Publié par Finviz · États-Unis il y a 9 h

Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard Time Upon closing,…

Lire l'article complet sur Finviz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finviz.com)

DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination

À lire aussi

MSA Safety beats top-line estimates; reaffirms FY26 outlook

Kosmos Energy (KOS) Q3 2026 Earnings Call Transcript

SLB (NYSE:SLB) Stock Breaks Below 50 Day Moving Average After Insider Selling

Australian, Chinese airline stocks jump as oil prices plunge more than 7%

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Stock market after midterm elections: What S&P 500 history shows

DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination

Partager

À lire aussi

MSA Safety beats top-line estimates; reaffirms FY26 outlook

Kosmos Energy (KOS) Q3 2026 Earnings Call Transcript

SLB (NYSE:SLB) Stock Breaks Below 50 Day Moving Average After Insider Selling

Australian, Chinese airline stocks jump as oil prices plunge more than 7%

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Stock market after midterm elections: What S&P 500 history shows